TY - JOUR
T1 - Grenz ray therapy in the new millennium
T2 - Still a valid treatment option?
AU - Warner, Jennifer A.
AU - Cruz, Ponciano D
PY - 2008/3
Y1 - 2008/3
N2 - Grenz ray therapy has declined in the United States during the past several decades with respect to availability, use, and resident training. However, it remains a simple, affordable, and effective option for managing several refractory dermatoses, especially psoriasis, hand eczema, and allergic contact dermatitis. Though high-dose grenz irradiation has been associated with the development of nonmelanoma skin cancers, grenz ray therapy is considered a safe treatment modality when administered according to the guidelines recommended herein. We review the value of grenz irradiation in contemporary dermatology.
AB - Grenz ray therapy has declined in the United States during the past several decades with respect to availability, use, and resident training. However, it remains a simple, affordable, and effective option for managing several refractory dermatoses, especially psoriasis, hand eczema, and allergic contact dermatitis. Though high-dose grenz irradiation has been associated with the development of nonmelanoma skin cancers, grenz ray therapy is considered a safe treatment modality when administered according to the guidelines recommended herein. We review the value of grenz irradiation in contemporary dermatology.
UR - http://www.scopus.com/inward/record.url?scp=44849126661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44849126661&partnerID=8YFLogxK
U2 - 10.2310/6620.2008.07078
DO - 10.2310/6620.2008.07078
M3 - Review article
C2 - 18413107
AN - SCOPUS:44849126661
SN - 1710-3568
VL - 19
SP - 73
EP - 80
JO - Dermatitis
JF - Dermatitis
IS - 2
ER -